Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)  Christian Möller, MD, PhDa, Sten.

Slides:



Advertisements
Similar presentations
Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia.
Advertisements

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes 
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Ulrich Wahn, MDa. ‡, Eli O. Meltzer, MDb. ‡, Albert F. Finn, MDc
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children  Mark Boguniewicz, MDa, Virginia C. Fiedler,
Richard L. ZuWallack, MD a,b, James P
Erika Lerch, MD, Ulrich R. Müller, MD 
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis 
The effect of omalizumab on nasal allergic inflammation
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Practice Notes from the AAAI
Badrul A. Chowdhury, MD, PhD 
Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma  Annika Wallin, PhDa, Malcolm Sue-Chu, PhDb, Leif Bjermer,
Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W
Predictors of positive food challenge outcome in non–IgE-mediated reactions to food in children with atopic dermatitis  Bodo Niggemann, MD, Susanne Reibel,
Elephantiasis nostras: A case report
The impact of allergic rhinitis on bronchial asthma
Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner,
Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic.
Phillip Lieberman, MD, Michael Tankersley, MD 
A review of the current guidelines for allergic rhinitis and asthma
Physician-targeted program on inhaled therapy for childhood asthma
Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge  Adriaan.
News & Notes Journal of Allergy and Clinical Immunology
Effect of probiotic Lactobacillus strains in children with atopic dermatitis  Vibeke Rosenfeldt, MD, PhDa,b, Eva Benfeldt, MD, PhDc, Susanne Dam Nielsen,
James P. Kemp, MDa, David A. Cook, MDb, Gary A
Phillip Lieberman, MD, David Golden, MD 
Allergens in school dust: II
Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization  Qutayba Hamid, MD, PhD, Editor  Journal.
Effect of ingested H1 antihistamines on methacholine challenge
IgE in unselected like-sexed monozygotic and dizygotic twins at birth and at 6 to 9 years of age: High but dissimilar genetic influence on IgE levels 
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma  William.
The pattern of atopic sensitization is associated with the development of asthma in childhood  Sabina Illi, MPHa,b, Erika von Mutius, MDb, Susanne Lau,
Patterns of pollen cross-allergenicity
Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray  Eli O. Meltzer,
Molecular virology and immunology of HIV infection
Evaluation of Allergen Immunotherapy
Susanne Halken, MDa, Arne Høst, MD, DMScb, Ulla Niklassen, MDc, Lars G
Autophagy: Nobel Prize 2016 and allergy and asthma research
News & Notes Journal of Allergy and Clinical Immunology
No correlation between wine intolerance and histamine content of wine
Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes 
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma  Eugene R. Bleecker, MDa, Michael J. Welch, MDb,
Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma  Yasurou Kohno, MDa,
Omalizumab improves asthma-related quality of life in patients with severe allergic asthma  Albert Finn, MDa, Gary Gross, MDb, Julius van Bavel, MDc,
A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein.
Intracellular IL-5 and T-lymphocyte subsets in atopic and nonatopic bronchial asthma  Yutaro Shiota, MD, PhDa, Hitomi Arikita, MTa, Naokatsu Horita, MDb,
Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled.
Seasonal intestinal inflammation in patients with birch pollen allergy
Practice Notes from the AAAI
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis  Ellinor Ädelroth, MD, PhDa, Sabina Rak, MD, PhDb,
Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma  James P.
Sami T. Remes, MD, MPHa,b, Jose A. Castro-Rodriguez, MDa, Catharine J
Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway.
Determinants of systemic manifestations of food allergy
Evidence for gene-environment interactions in a linkage study of asthma and smoking exposure  Susan Colilla, PhDa*, Dan Nicolae, PhDb, Anna Pluzhnikov,
Atopy patch tests, together with determination of specific IgE levels, reduce the need for oral food challenges in children with atopic dermatitis  Charles.
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Footnotes1 Journal of Allergy and Clinical Immunology
National trends in asthma visits and asthma pharmacotherapy,
Larry C. Borish, MDa, Harold S
Exhaled carbon monoxide levels after a course of oral prednisone in children with asthma exacerbation  Stefania Zanconato, MD, PhD, Massimo Scollo, MD,
Andrea J. Apter, MD, MSca, c, Susan T
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial  Eli O. Meltzer, MDa,
News & Notes Journal of Allergy and Clinical Immunology
Presentation transcript:

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)  Christian Möller, MD, PhDa, Sten Dreborg, MD, PhDb, Hosne A. Ferdousi, MDc, Susanne Halken, MDd, Arne Høst, MD, PhDe, Lars Jacobsen, MScf, Antti Koivikko, MD, PhDg, Dieter Y. Koller, MDh, Bodo Niggemann, MDi, Lene A. Norberg, MDe, Radvan Urbanek, MD, PhDh, Erkka Valovirta, MD, PhDg, Ulrich Wahn, MD, PhDi  Journal of Allergy and Clinical Immunology  Volume 109, Issue 2, Pages 251-256 (February 2002) DOI: 10.1067/mai.2002.121317 Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 1 Flow chart of the study. Journal of Allergy and Clinical Immunology 2002 109, 251-256DOI: (10.1067/mai.2002.121317) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 2 Development of BHR (methacholine challenge test) within each group measured as natural logarithm of PC20 change from baseline (a) in the season of pollen exposure and (b) during the winter. Journal of Allergy and Clinical Immunology 2002 109, 251-256DOI: (10.1067/mai.2002.121317) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 3 The percentage of children after 3 years of immunotherapy with and without asthma among those without asthma before treatment (N = 151). The absolute numbers of children are shown above the bars . Journal of Allergy and Clinical Immunology 2002 109, 251-256DOI: (10.1067/mai.2002.121317) Copyright © 2002 Mosby, Inc. Terms and Conditions